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Abstract
Vitamin A deficiency (VAD) is an important contributor to child morbidity and mortality. The 
prevalence of VAD, measured by retinol-binding protein (RBP) or retinol, is overestimated in 
populations with a high prevalence of inflammation. We aimed to quantify and adjust for the effect 
of inflammation on VAD prevalence in a nationally representative survey of Liberian children 6 to 
35 months of age. We compared five approaches to adjust RBP for inflammation and estimate 
VAD prevalence (defined as RBP <0.7 μmol/L): (1) ignoring inflammation; (2) excluding 
individuals with inflammation (C-reactive protein (CRP) >5 mg/L or alpha1-acid glycoprotein 
(AGP) >1 g/)L; (3) multiplying each individual’s RBP by an internal correction factor; (4) by an 
external correction factor; and (5) using regression (corrected RBP = exp(InRBP – β1(lnCRPobs-
lnCRPref) – β2(lnAGPobs-lnAGPref)). Corrected RBP was based on a regression model where 
reference lnCRP and lnAGP were set to the maximum of the lowest decile. The unadjusted 
prevalence of VAD was 24.7%. Children with elevated CRP and/or AGP had significantly lower 
RBP concentrations than their apparently healthy peers (geometric mean RBP 0.79 μmol/L (95% 
CI: 0.76, 0.82) vs. 0.95 μmol/L (95% CI: 0.92, 0.97), P <0.001). Using approaches 2–5 resulted in 
a prevalence of VAD of 11.6%, 14.3%, 13.5% and 7.3%, respectively. Depending on the approach, 
the VAD prevalence is reduced 10–17 percentage points when inflammation is taken into account. 
Further quantification of the influence of inflammation on biomarkers of vitamin A status from 
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other national surveys is needed to compare and recommend the preferred adjustment approach 
across populations.
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Introduction
Vitamin A deficiency (VAD) is a major public health issue in many resource-poor settings of 
the world (Taren 2012). It is estimated that 33%, or 190 million children, worldwide are 
vitamin A deficient (WHO 2009). The importance of VAD is well established with respect to 
child mortality and morbidity (Tanumihardjo 2012; Taren 2012). While there has been 
important progress globally with respect to the alleviation of overt signs of VAD, 
biochemical data suggest a persistent, elevated prevalence of low vitamin A status, with 
important impacts on growth, vision, immune function and reproduction (Ross et al. 2000). 
To assess the prevalence of VAD in a population, valid and reliable biomarkers for vitamin A 
status are necessary.
Nearly all vitamin A in the blood is associated with retinol-binding protein (RBP). 
Therefore, serum RBP can be used as a surrogate measure for retinol content, the 
predominant circulating form of vitamin A in the blood, or vitamin A status (Erhardt et al. 
2004). Some studies suggest that the molar ratio of retinol : RBP is not 1:1 (Gorstein et al. 
2008; Engle-Stone et al. 2011) and may change throughout the inflammation response 
(Willumsen et al. 1997); however, this 1:1 ratio is adopted by the World Health Organization 
(WHO 2011). RBP is affected by the acute-phase response, resulting in interpretations of 
VAD prevalence, which are likely not reflective of actual vitamin A status in populations 
with high levels of inflammation and infection. Proteins whose concentrations change as 
part of the acute-phase response are referred to as acute-phase proteins (APP). RBP is itself 
a negative APP and its concentration temporarily decreases in response to inflammation, 
reflecting the decreased synthesis of RBP (Louw et al. 1992). Positive acute-phase proteins, 
such as C-reactive protein (CRP) and α-1 acid glycoprotein (AGP), are synthesized by the 
liver. CRP can increase 20 to 1000-fold and AGP can increase two to fivefold in response to 
inflammation (Koj 1985). The more severe the inflammation or infection, the more of an 
effect the acute-phase response has on RBP (Duncan et al. 2012); therefore, the 
measurement of CRP and AGP can assist in the correct interpretation of this biochemical 
marker of vitamin A status.
A meta-analysis of the effect of subclinical infection on plasma retinol concentrations found 
that the geometric mean retinol was reduced from anywhere between 11% to 24%, 
depending on the stage of inflammation (Thurnham et al. 2003). Despite the research 
demonstrating a definite temporary and concurrent response of retinol and RBP to 
commonly measured APPs, there is no current consensus on how to correct vitamin A bio-
markers for the influence of inflammation (WHO 2011). Some have proposed using a new 
cutoff to determine vitamin A deficiency among individuals with elevated APP 
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concentrations (Paracha et al. 2000). Others suggest using correction factors to adjust 
individuals’ retinol and RBP concentrations based on their stage of inflammation, often 
categorized as the incubation, early and late convalescence stages (Thurnham et al. 2003; 
Baingana et al. 2013). The role of inflammation on micronutrient biomarker levels has been 
identified as a critical research gap (Raiten et al. 2015).
The aim of this study was to present various approaches for adjusting for inflammation when 
measuring RBP and how they affect VAD prevalence in a high-inflammation population of 
Liberian children aged between 6 to 35 months. We go beyond previous research to show the 
effect of adjustment using a continuous approach (‘the regression approach’), which 
accounts for inflammation in a continuous manner, rather than relying on previously 
identified categories of inflammation (Thurnham et al. 2003). Such a concept was deemed 
appropriate given the substantial variation observed in RBP concentrations above and below 
the CRP and AGP cutoffs that currently define inflammation (Suchdev et al. in press). We 
also examined the effect of malaria on VAD independently and in addition to the effect of 
CRP and AGP. This analysis is of particular interest given it examines VAD in a country that 
usually has wide coverage of their vitamin A capsule programme.
Methods
Study population
This secondary analysis is based on a nationally representative micronutrient survey, the 
National Micronutrient Survey (NMS), in Liberia. The NMS was conducted in a 
representative sample of 1434 Liberian children aged between 6 to 35 months from urban 
and rural areas between April and June 2011, with the primary objective of determining the 
national and rural/urban prevalence of key micronutrient deficiencies among children. 
Detailed descriptions of the study population and methods have been described elsewhere 
(LISGIS & UNICEF 2011). Briefly, this was a two-stage cluster design that stratified the 
country into urban and rural areas. Probability proportional to size was used to select 57 
communities from within each stratum. In each cluster, 15 households were systematically 
sampled to give a sample of 1710 households. The survey collected socio-economic, health 
and nutrition information from the children. The survey also assessed infant and young child 
feeding practices, nutritional biomarkers as well as anthropometry, measured following 
standardized techniques. Signed informed consent was obtained from the parent or legal 
guardian of the child, and verbal assent was obtained from the child. Ethical approval was 
received from the Liberia Ethics Committee. A total of 1484 children under five completed 
the assessments, corresponding to a 98% eligible children response rate. Of these, 1434 had 
complete information that was used in the following analyses.
Key messages
• Ignoring inflammation in resource-poor settings can lead to the incorrect 
diagnosis of vitamin A deficiency in individuals, as well as overestimation of 
the prevalence of vitamin A deficiency in a population.
• The application of different adjustment techniques to RBP data in Liberian 
children 6–35 months of age reduces unadjusted vitamin A deficiency 
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prevalence from 25% by 10 to 17 percentage points, influencing the 
interpretation of the magnitude of the public health problem.
• Quantification of the influence of inflammation on biomarkers of vitamin A 
status from other national surveys is needed to compare and recommend the 
preferred adjustment approach across populations.
Biochemical assessments and laboratory methods
Hemoglobin was assessed with the Hemocue 201+, and serum samples were collected from 
all eligible children to measure RBP, CRP and AGP. A venous blood sample of two 
milliliters was drawn from each child in a vacutainer tube. Immediately after collection, 
whole blood samples were placed in self-cooling containers containing frozen gel packs and 
outfitted with racks, additional foam insulation, and recording digital thermometers. Every 
day, following a minimum 2-h period without movement, aliquots of serum were drawn off 
from the top of each whole blood sample collected that day and transferred to smaller serum 
vials. Serum samples were stored at −15°C and shipped to VitMin, Germany. RBP, CRP and 
AGP concentrations were measured with an optimized sandwich enzyme-linked 
immunosorbent assay technique in duplicate in 15 μL serum (Erhardt et al. 2004). Clinical 
serum controls were used for calibration purposes and quality control samples from the 
Centers for Disease Control and Prevention in Atlanta were used to check the absolute 
values. A retinol : RBP ratio of 1:1 was assumed, and the cutoff value for RBP in children to 
define VAD was taken as <0.7 μmol/L (WHO 2011). Malaria was measured using a rapid 
diagnostic test, the Paracheck Pf test (Orchid Biomedical System, Goa, India).
Statistical analyses
The analyses were conducted in collaboration with the Biomarkers Reflecting Inflammation 
and Nutrition Determinants of Anemia working group, which has been working to identify 
an appropriate method to account for inflammation when measuring nutrition biomarkers 
(Suchdev et al. in press). Descriptive and biochemical status statistics were calculated for 
variables of interest. All analyses were weighted for the complex survey design. Five 
approaches were compared to adjust RBP for elevated APPs in order to account for the 
effect of subclinical inflammation on the assessment of vitamin A deficiency, based on a 
recent review (Raiten et al. 2015). Approach 1 ignored concurrent inflammation as defined 
by elevated CRP (>5 mg/L) or AGP (>1 g/L). Approach 2 excluded those with elevated 
APPs (CRP >5 mg/L and/or AGP >1 g/L). Approach 3 used internal correction factors based 
on a four-level model of inflammation: the incubation period (CRP >5 mg/L and AGP ≤ 1 
g/L), early convalescence (CRP >5 mg/L and AGP >1 g/L), late convalescence (CRP ≤ 5 
mg/L and AGP >1 g/L) and apparently healthy (CRP ≤ 5 mg/L and AGP ≤ 1 g/L). Level-
specific adjustment factors were calculated as the ratios of geometric mean RBP for 
apparently healthy children to geometric mean RBP for those in the incubation period, the 
early convalescence period and the late convalescence period. Each individual’s RBP value 
was then multiplied by their corresponding correction factor (based on their stage of 
inflammation) to estimate an adjusted RBP concentration. Approach 4 used correction 
factors established by the meta-analysis of Thurnham et al. (2003), which are based on the 
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same four-level model of inflammation. This meta-analysis used CRP, AGP and retinol data 
from 15 studies to calculate correction factors that could be applied to any dataset with 
retinol values. Because we assumed a retinol : RBP ratio of 1:1, we applied these correction 
factors to our RBP concentrations. Finally, Approach 5 employed a multiple linear 
regression model to obtain adjusted RBP concentrations: adjusted RBP = exp [unadjusted 
lnRBP – (regression coefficient for lnCRP) *(lnCRP-(−1.47)) – (regression coefficient for 
lnAGP) *(lnAGP-(−0.36)] (Suchdev et al. in press). RBP, CRP and AGP were ln 
transformed to reflect better regression diagnostics. The adjusted RBP was calculated by 
subtracting the influence of CRP and/or AGP. A reference concentration was subtracted 
from measured lnCRP and lnAGP values to mimic individuals with low levels of APPs and 
to avoid over-adjusting RBP by excluding low levels of inflammation from the regression 
adjustment. There are not previously well-defined cutoffs for CRP or AGP, specifically 
looking for the effects of inflammation on RBP concentrations, so the reference 
concentrations used were the maximum values of the lowest decile found in the sampled 
population, or lnCRP = −1.47 ln(mg/L) and lnAGP = −0.36 ln(g/L). These reference 
concentrations were chosen after running sensitivity analyses that demonstrated little change 
in the prevalence of VAD when using other low levels of APPs that were based on our 
literature review of low inflammation populations. This regression approach adjustment was 
only applied to individuals with lnCRP and lnAGP concentrations at or above the reference 
values, as those below are thought to be uninflamed individuals with unduly influenced RBP 
concentrations and therefore needing no inflammation correction. We also used this 
approach to control for the effect of malaria to examine its independent effect on RBP. In 
order to measure its effect in addition to what we observe from elevated CRP and AGP, we 
stratified adjusted RBP concentrations and VAD prevalence (based on the regression 
approach to adjust for CRP and AGP) by malaria status. VAD prevalence was calculated 
based on the adjusted RBP levels computed in each case.
Data analysis was done using SAS 9.3 (SAS Institute, North Carolina) following complex 
survey analytic techniques. PROC SURVEYMEANS was used to calculate the mean of 
continuous demographic and biochemical characteristics. PROC SURVEYFREQ was used 
to calculate frequencies and to test for differences in proportions of categorical background 
characteristics, as well as prevalence of vitamin A deficiency resulting from each adjustment 
approach. Adjustments made using linear regression to subtract the effect of inflammation 
were done with PROC SURVEYREG. A P-value of less than 0.05 was used to assess 
statistical significance.
Results
Basic demographic, nutritional and inflammation-related characteristics are presented in 
Table 1. There was an equal proportion of women and men, with more living in rural areas. 
Prevalence of wasting, stunting and underweight was 9.2%, 35.1% and 23.2%, respectively. 
Almost a third of the children had positive malaria status based on a rapid diagnostic test, 
and among those with elevated CRP and AGP, most were in the early or late stages of 
convalescence. The prevalence of elevated CRP was significantly higher among children 12–
35 months of age compared with children 6–11 months (31.0% vs. 24.9%, P = 0.04), 
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whereas the prevalence of elevated AGP was significantly lower among older children 
(37.2% vs. 45.1%, P = 0.0004).
The prevalence of VAD was significantly higher among children with malaria compared 
with those without (37.7% vs. 19.3%, P <0.0001). The weighted means of RBP, CRP and 
AGP significantly differed by stage of inflammation. Geometric means for RBP in children 
in the apparently healthy, incubation, early and late convalescence stages of inflammation 
were 0.95 μmol/L, 0.86 μmol/L, 0.70μmol/L and 0.87μmol/L, respectively (P <0.0001). The 
weighted means for CRP in each of the stages were 1.0 mg/L, 11.3 mg/L, 19.3 mg/L and 2.1 
mg/L, respectively (P <0.0001), and for AGP, they were 0.8 g/L, 0.9 g/L, 1.3 g/L and 1.2 
g/L, respectively (P <0.0001). RBP significantly decreased with increasing deciles of CRP 
and AGP while the prevalence of VAD significantly increased (Figs 1, 2). This trend was 
observed irrespective of the inflammation cutoffs of CRP = 5 mg/L and AGP = 1 g/L, 
reinforcing the need for a continuous approach to adjust for inflammation, such as the 
‘regression approach’.
The adjusted VAD prevalence using each of the described approaches is displayed in Table 
2. Ignoring inflammation, the VAD prevalence in this population of children was 24.7%. 
Excluding individuals with inflammation reduced the prevalence of VAD to 11.6%. Internal 
correction factors were calculated as 1.10 for children in the incubation phase, 1.34 for those 
in the early convalescence phase, and 1.09 for children in the late convalescence phase of 
inflammation. Correction factors established by Thurnham et al. (2003) in their meta-
analysis are 1.14 for those in the incubation phase, 1.31 for those in the early convalescence 
phase and 1.12 for those in the late convalescence phase. Using the internal and Thurnham et 
al. (2003) correction factors on individuals’ RBP concentrations resulted in prevalence 
estimates of VAD of 14.3% and 13.5%, respectively. Using linear regression to adjust for 
malaria status decreased the prevalence of VAD to 18.8%, and using linear regression to 
adjust for AGP and CRP decreased the prevalence to 7.3%. Even after adjusting RBP for 
CRP and AGP using the regression approach, there was a significant difference in RBP 
concentrations and VAD prevalence among children with and without malaria (10.7% (95% 
CI: 7.3, 14.1) vs. 5.9% (95% CI: 4.4, 7.5), P = 0.023).
The strong correlation (r = 0.6, P <0.0001) between CRP and AGP demonstrated that they 
partially share variance in their quantification of inflammation. RBP was significantly 
correlated with both CRP (r = −0.3, P <0.0001) and AGP (r = −0.3, P <0.0001). The 
multiple linear regression model indicated that lnCRP and lnAGP were not collinear and that 
16% of the variance in lnRBP was explained by lnCRP and lnAGP.
Discussion
The results of this study indicate that approximately 60% of the children in this national 
survey had elevated APPs. The children in the incubation, early and late convalescence 
stages of inflammation had significantly lower RBP levels than those who were apparently 
healthy, with a corresponding higher prevalence of VAD. The findings demonstrate that the 
statistical adjustment of RBP levels for inflammation results in substantially lower estimates 
of VAD compared with not adjusting for it in a resource-poor setting with high rates of 
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inflammation. During an acute-phase response, RBP levels may be temporarily reduced 
because of decreased synthesis of RBP (Thurnham & Singkamani 1991); however, this may 
be reflective of the underlying infection, not the individual’s actual vitamin A status. The 
effect of inflammation on decreasing concentrations of vitamin A biomarkers, occurring 
independently of actual vitamin A status, has been previously reported (Filteau et al. 1993, 
1995; Paracha et al. 2000; Wieringa et al. 2002; Thurnham et al. 2003; Baingana et al. 2013; 
Schulze et al. 2014; Wessells et al. 2014). Reductions in RBP during the acute-phase 
response are transitory and its concentration is likely to return to normal once the infection 
or trauma has subsided (Filteau et al. 1993). Therefore, the estimation of VAD prevalence in 
the population is likely overestimated if no adjustment is made for APPs.
The objective of this analysis was to estimate and correct for the influence of inflammation 
(as measured by elevated CRP and AGP) on RBP levels and VAD prevalence in children 6 to 
35 months of age in Liberia using five different approaches. To our knowledge, this is the 
first study to present a comparison of approaches to adjust for inflammation on VAD 
prevalence and the first to use a linear regression model to account for the transient effect of 
APPs on RBP concentrations. All the adjustment approaches significantly reduced the 
prevalence of VAD compared with ignoring inflammation. We also confirm previous 
findings that excluding children with raised APPs may not be the most appropriate approach 
for adjusting for inflammation in the estimation of VAD because it results in a much reduced 
sample size, especially in younger children with high rates of morbidity. Others have also 
found potential sample bias with this approach (Maqsood et al. 2004; Baingana et al. 2013). 
Internal correction factors were similar in magnitude to those found in the meta-analysis by 
Thurnham et al. (2003), which supports the latter’s applicability to survey data that do not 
have the capacity or sample size to calculate internal correction factors. Using internal or 
external (Thurnham et al. 2003) corrections factors significantly reduces the prevalence of 
VAD; however, it categorizes individuals into stages of inflammation in which there is still 
considerable variability in RBP concentrations. The regression approach may offer some 
advantage and precision when controlling for these APPs because it retains the entire sample 
size and it better reflects the association between RBP and the entire range of APPs, not 
needing to rely on predefined cutoffs of CRP = 5 mg/L and AGP = 1 g/L. Our results show 
that using the regression approach to control for the effect of CRP and AGP leads to a much 
lower adjusted prevalence of VAD compared with ignoring inflammation. However, in 
certain populations, the inflammatory role of APPs may exhibit curvilinear or plateau 
relationships with RBP, and a linear regression coefficient alone may not fully quantify their 
full inflammatory effect. Nevertheless, it is also possible that residual confounding or 
mediation from covariates not considered in this study, or interactions among those 
modelled, might alter the type of relationship between RBP and APPs via mechanisms that 
could themselves, be either synergistic or antagonistic (bidirectional) (Szklo & Nieto 2012), 
and less likely to discount the observed main effects of APPs on RBP concentration. A 
larger study, as planned by Biomarkers Reflecting Inflammation and Nutrition Determinants 
of Anemia, with more diverse populations could further elucidate these mechanisms and 
determine whether the findings are consistent across countries with high and low 
inflammation prevalence.
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Prior to any adjustment, the levels of VAD suggested a severe public health problem (WHO 
1996). In the present study, adjusting for inflammation using internal and external correction 
factors resulted in a prevalence of VAD that is indicative of a moderate public health 
problem. Using linear regression to adjust for CRP and AGP reduced the prevalence to a 
mild public health problem. Although this study was conducted in children who are 
vulnerable to nutritional deficiencies and infection, almost all children (91.2%) had received 
vitamin A supplementation in the past 6 months through the country’s semi-annual vitamin 
A supplementation campaign, which is integrated with immunization services through the 
Ministry of Health of Liberia. This may explain the low levels of VAD after adjustment for 
inflammation. However, similar to what has been previously found in response to universal 
vitamin A supplementation strategies (Palmer et al. 2012), mean RBP concentration was not 
significantly different among children who had and had not received vitamin A 
supplementation in the past 6 months, as was the absolute risk of vitamin A deficiency. This 
observation was held before and after adjustment for APPs.
In the present study, there was a significant added effect of malaria status on RBP 
concentrations and VAD prevalence estimates even after adjusting for CRP and AGP using 
the regression approach, a finding that is consistent with a recent study, which examined the 
association of malaria and inflammation-corrected RBP (Wessells et al. 2014). Wessells et 
al. (2014) reported that in young children in Burkina Faso there was a significant association 
between elevated plasma histidine-rich protein II and RBP even after adjusting for APPs 
using correction factors. In our findings, using multiple linear regression to account for the 
effects of CRP and AGP may not have fully captured the effect of malaria status on RBP 
concentrations. The effects of malaria infection on reducing RBP and retinol concentrations 
have been shown to be transitory (Filteau et al. 1993); thus, statistical adjustments to correct 
for both elevated APPs and malaria infection need to be explored.
Because of its cross-sectional nature, the results of the current study are not evidence for a 
causal effect of the inflammatory response on RBP concentrations. Physiologic processes 
that alter both nutritional status and inflammation could exist, therefore confounding the 
association between the two. For instance, a child with malaria could have higher 
inflammation and a reduced appetite resulting in reduced nutrient intakes, such as vitamin A. 
Therefore, the reduced RBP levels would be a reflection of the child’s nutrient status and not 
only a response to the inflammation itself (Duncan et al. 2012). A further limitation of this 
study is that information on the causes of inflammation in this population was not 
concurrently measured in this survey. Causes of inflammation other than malaria, such as 
intestinal parasites, respiratory infections and HIV, could affect vitamin A metabolism in 
addition to or independent of what is observed from elevated CRP and AGP. A final 
limitation of our study is the lack of calibration between RBP and serum retinol, and if the 
molar ratio of 1:1 does not hold in this population, then the cutoff point of <0.7 μmol/L 
should be adjusted. However, this would not change our main conclusion. In fact, using a 
cutoff of <0.84 μmol/L (Gorstein et al. 2008; Engle-Stone et al. 2011) with the regression 
adjustment approach resulted in a prevalence that was 24 percentage points lower than the 
VAD prevalence without adjustment. Serum retinol is the recommended biomarker for 
determining population level VAD; however, because of the high cost for this analysis, the 
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measurement of RBP may be preferred in low-income and middle-income countries where 
high levels of inflammation are often seen (Erhardt et al. 2004).
Nonetheless, our results highlight the importance of inflammation on the interpretation of 
VAD in a population of young children, independent of actual vitamin A status. Accounting 
for inflammation may have important implications for evaluating vitamin A supplementation 
and fortification programmes. The findings demonstrate that taking into account APPs in a 
population survey reduces the prevalence of VAD. We present five approaches to adjust for 
inflammation when evaluating levels of RBP with the notion that this could help estimate 
VAD prevalence more accurately. The influence of adjusting for APPs on biomarkers of 
vitamin A status using these five approaches needs to be further investigated, so as to 
recommend a preferred adjustment approach across populations with high levels of 
inflammation. As such, we recommend reporting unadjusted findings in addition to any 
adjusted results.
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Table 1
Demographic and biochemical characteristics of a nationally representative population of Liberian children 6 
to 35 months of age (n = 1434)1
Characteristics Weighted % (n) or mean 95% CI
Age (months) 19.9 19.4, 20.4
Men 50.4 (720) 47.6, 53.2
Rural 62.5 (590) 59.0, 66.0
Positive malaria status 29.4 (348) 26.2, 32.6
Recent diarrhoea (in the past 2 weeks) 46.6 (656) 43.3, 50.0
Recent fever (in the past 2 weeks) 71.8 (1023) 68.7, 74.9
Anaemia (hemoglobin < 110 g/L) 59.5 (833) 55.6, 63.4
Wasting (WHZ < −2 SD) 9.2 (150) 7.4, 11.0
Stunting (HAZ < −2 SD) 35.1 (841) 32.0, 38.2
Underweight (WAZ < −2 SD) 23.2 (349) 20.9, 25.5
Received vitamin A supplementation in the past 6 months 91.2 (1239) 88.9, 93.4
RBP < 0.70 μmol/L 24.7 (351) 21.2, 28.1
CRP > 5 mg/L 29.5 (375) 26.5, 32.5
AGP > 1 g/L 56.2 (762) 52.5, 60.0
Any inflammation (CRP > 5 mg/L or AGP > 1 g/L) 59.1 (801) 55.6, 62.7
Stage of inflammation
 Apparently healthy (CRP ≤5 mg/L and AGP ≤1 g/L) 40.9 (633) 37.3, 44.4
 Incubation (CRP >5 mg/L and AGP ≤1 g/L) 2.9 (39) 2.0, 3.9
 Early convalescence (CRP >5 mg/L and AGP >1 g/L) 26.6 (336) 23.7, 29.6
 Late convalescence (CRP ≤5 mg/L and AGP >1 g/L) 29.6 (426) 26.4, 32.8
1
CI, confidence interval; SD, standard deviation; WHZ, weight-for-height Z-score; HAZ, height-for-age Z-score; WAZ, weight-for-age Z-score; 
CRP, C-Reactive Protein; AGP, α1-acid-glycoprotein.
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Table 2
Summary of vitamin A deficiency by approach (weighted analysis)†
Approach Prevalence of vitamin A deficiency (95% CI)
Approach 1: Ignoring APPs 24.7 (21.2, 28.1)
Approach 2: Excluding those with elevated APP (CRP and/or AGP) 11.6 (8.4, 14.8)
Approach 3: Adjusting RBP using internal correction factors†† 14.3 (11.9, 16.8)
Approach 4: Adjusting RBP using Thurnham et al.’s (2003) correction factors††† 13.5 (11.1, 15.9)
Approach 5: Adjusting RBP using regression approach†††† 7.3 (5.7, 9.0)
†
APP, acute-phase protein; CRP, C-reactive protein; AGP, α1-acid-glycoprotein; RBP, retinol-binding protein; VAD prevalence defined as defined 
as RBP < 0.7 μmol/L; elevated CRP defined as CRP > 5 mg/L; elevated AGP defined as AGP > 1 g/L.
††
Internal correction factors: CRP = 1.10, CRP + AGP = 1.34, AGP = 1.09.
†††
Thurnham correction factors: CRP = 1.14, CRP + AGP = 1.31, AGP = 1.12.
††††
Adjusted RBP = exp[unadjusted lnRBP – (regression coefficient for lnCRP)*(lnCRP-(−1.47)) – (regression coefficient for lnAGP)*(lnAGP-
(−0.36))].
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